Application
SLMO2 Antibody (Center) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the SLMO2 antibody detected the SLMO2 protein (arrow).Application
SLMO2 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human liver tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SLMO2 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | SLMO2 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SLMO2; C20orf45; Protein slowmo homolog 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | C20orf45 |
|---|---|
| Alternative Names | SLMO2 C20orf45 Protein slowmo homolog 2 |
| Molecular Weight(MW) | 21495 Da |
| Tissue Specificity | This SLMO2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 99-129 amino acids from the Central region of human SLMO2. |
| Entrez Gene | 51012 |
|---|---|
| Nucleotide Accession | NP_057129.2 |
Application
SLMO2 Antibody (Center) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the SLMO2 antibody detected the SLMO2 protein (arrow).
Application
SLMO2 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human liver tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SLMO2 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
